NM_001205293.3:c.1056-3374A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001205293.3(CACNA1E):​c.1056-3374A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.128 in 152,134 control chromosomes in the GnomAD database, including 1,324 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.13 ( 1324 hom., cov: 32)

Consequence

CACNA1E
NM_001205293.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.303

Publications

4 publications found
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 69
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.179 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ENM_001205293.3 linkc.1056-3374A>G intron_variant Intron 7 of 47 ENST00000367573.7 NP_001192222.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1EENST00000367573.7 linkc.1056-3374A>G intron_variant Intron 7 of 47 1 NM_001205293.3 ENSP00000356545.2
CACNA1EENST00000360108.7 linkc.1056-3374A>G intron_variant Intron 7 of 46 5 ENSP00000353222.3
CACNA1EENST00000367570.6 linkc.1056-3374A>G intron_variant Intron 7 of 46 1 ENSP00000356542.1
CACNA1EENST00000621791.4 linkc.1056-3374A>G intron_variant Intron 7 of 45 1 ENSP00000481619.1
CACNA1EENST00000524607.6 linkc.1491-3374A>G intron_variant Intron 9 of 11 5 ENSP00000432038.2

Frequencies

GnomAD3 genomes
AF:
0.128
AC:
19501
AN:
152016
Hom.:
1319
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0940
Gnomad AMI
AF:
0.0789
Gnomad AMR
AF:
0.185
Gnomad ASJ
AF:
0.103
Gnomad EAS
AF:
0.0197
Gnomad SAS
AF:
0.106
Gnomad FIN
AF:
0.157
Gnomad MID
AF:
0.146
Gnomad NFE
AF:
0.143
Gnomad OTH
AF:
0.147
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.128
AC:
19529
AN:
152134
Hom.:
1324
Cov.:
32
AF XY:
0.127
AC XY:
9451
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.0941
AC:
3905
AN:
41520
American (AMR)
AF:
0.185
AC:
2826
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.103
AC:
359
AN:
3470
East Asian (EAS)
AF:
0.0197
AC:
102
AN:
5176
South Asian (SAS)
AF:
0.106
AC:
510
AN:
4822
European-Finnish (FIN)
AF:
0.157
AC:
1666
AN:
10582
Middle Eastern (MID)
AF:
0.164
AC:
48
AN:
292
European-Non Finnish (NFE)
AF:
0.143
AC:
9732
AN:
67978
Other (OTH)
AF:
0.146
AC:
309
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
864
1728
2593
3457
4321
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
218
436
654
872
1090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.138
Hom.:
827
Bravo
AF:
0.130
Asia WGS
AF:
0.0860
AC:
298
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
5.1
DANN
Benign
0.26
PhyloP100
0.30
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4306091; hg19: chr1-181676716; API